New Chances Matter

Offer the chance to all patients with end-stage chronic disease to be treated with transplantation

Who we are

AN INNOVATIVE SMALL-SIZED COMPANY, SERVING MEDICINE

IGL is a medical technology company specializing in the preservation of donor organs and tissues intended to transplantation.

IN THE BEGINNING THERE WAS A PATIENT…

In 1968 and 1998, Georges Gaston Lopez, received a kidney and liver transplant. Later, his son, Georges Antoine Lopez, founded Institut Georges Lopez (known as IGL), a company entirely devoted to donor organ preservation.
It is because we understand what it feels like to be waiting for an organ, that we are committed to  constantly provide safe and innovative products, in order to ensures transplantation success and improves patient’s quality of life.

Decades of passion, research and experience have forged the reputation of our products.

Our values

IGL commitment is to provide the best quality and innovative products to ensure transplantation success and improve patients' quality of life

Patient oriented

In the beginning there was a patient… Our duty is to think patient.

Quality

Our quality policy: support transplant teams, ensure the safety and performance of our products, be efficient, be responsible. All our solutions have a CE marking according to MDR 2017/745.

Innovation

Our state of mind, the desire for continuous improvement.

Ethics

Expertise, Proximity, Corporate culture.

Cohesion

IGL is a group of employees who share a common vision, values, trajectory and objectives. Everything is closely linked to the sense of belonging.

Contact us

Our missions

A high success rate, recognized efficiency...

Our objective :

  • Offer the chance to all patients with terminal chronic diseases to be treated through transplantation.
  • Support the transplant teams.
  • Ensure security and performance of our products.
  • Offer advanced solutions and systems to expand the number of transplantable organs and improve transplant outcomes.
Contact us

Where we started

Our history

- 2005 -

Launch of IGL-1®, a solution for abdominal organs

- 2007 -

Acquisition of Waters Medical Systems LLC (Rochester, Minnesota USA)

- 2009 -

Creation of IGL America Latina (Porto Alegre, Brazil)

- 2012 -

Launch of WAVES®, transportable renal perfusion system

- 2014 -

Acquisition of CELSIOR® solution for abdominal and thoracic organs (from Sanofi Genzyme)

- 2015 -

Obtention of Pharmaceutical establishment status

- 2022 -

Obtention of production authorization for IGL AMERICA LATINA

- 2023 -

- Launch of RM4, two kidneys Perfusion Machine, on the US market
- Obtention of the CE marking according to regulation 2017/745 (MDR) for IGL-1, BEL-GEN and PERF-GEN

- 2003 -

Creation of the company Institut Georges Lopez (Lyon region, France)

Leadership

The team

Alexandre LOPEZ

CEO of IGL

Michael Christ

Managing Director, North America

Omer Uyanik

Vice President of Product Development

Matthieu Prouteau

Head Pharmacist & Vice-President of Quality

Humberto Sobrinho

Managing Director, Latin America

Leadership

The team

Alexandre LOPEZ

CEO of IGL

Alexandre started his role of CEO in 2021. 3rd generation, he served previously in the role of R&D Director within IGL. Alexandre received his PhD in physiology & pathophysiology from Paris-Saclay University. His PhD thesis focused on new markers of viability for normal and steatotic liver grafts.

Michael Christ

Managing Director, North America

Michael has 20+ years’ experience in medical industry. He served in various leadership roles within IGL. He also had an experience at Zimmer Biomet Robotics and Thermo Fisher Scientific. Michael graduated from INSA Strasbourg Engineering School.

Omer Uyanik

Vice President of Product Development

Omer has 15+ years’ experience in biomedical engineering. He started within IGL in 2008 and since then he served in various engineering role within the company. Omer graduated in Biomedical Engineering from Lyon University.

Matthieu Prouteau

Head Pharmacist & Vice-President of Quality

Matthieu has 15+ years’ experience in pharmaceutical industry. Prior to joining IGL in 2019, he held various positions within Gifrer Laboratory, physiological serum manufacturer, from 2008 to June 2019, with his last assignment serving as Head Pharmacist. Matthieu received his doctorate in pharmacy from the University of Limoges (FR)

Humberto Sobrinho

Managing Director, Latin America

Humberto has 20+ years’ experience in medical industry. He has been partnering with IGL since the creation of the IGL brazilian subsidiary in 2009. Prior to that, Humberto held various sales positions within pharmaceutical companies, including Dr. Franz Köhler Chemie GmbH.
Humberto holds a degree in pharmacy from Rio Grande do Sul University, Brazil. He also obtained an MBA from ESPM business school in São Paulo, Brazil.

Write us

Our location

Institut Georges Lopez, more often called IGL, is made up of a network of subsidiaries and partner distributors around the world.
We are therefore never far from our customers and can therefore help them meet their local challenges.

For a request concerning any other country, please contact our Headquarter in France

IGL GROUP HEADQUARTER
Institut Georges Lopez, SAS
Parc Tertiaire du Bois Dieu
RN6 – 1 allée des Chevreuils
69380 Lissieu
France

Téléphone : +33(0)4 37 64 63 32

Fax : +33(0)4 37 64 60 09

France

Institut Georges Lopez, SAS
Parc Tertiaire du Bois Dieu
RN6 – 1 allée des Chevreuils
69380 Lissieu
France

North America

Waters Medical Systems LLC
2112 15th Street Northwest,
Rochester, Minnesota 55901,
United States

Latin America

IGL AMÉRICA LATINA, LTD
Avenida Levy Ramos Martins, 8686, Nova Brasília
88780-000 Imbituba
Santa Catarina,
Brasil

Italy

IGL ITALIA SRL
Via S. Benedetto N.45/C
35037 TEOLO (PD)
Italia

Spain

IGL SPAIN
Eduardo Torroja, 22-Naves 19 y 20
28823-COSLADA (MADRID)